Global Api Intermediates Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2023 –2030 |
 시장 규모(기준 연도) |
USD 2.34 Billion |
 시장 규모(예측 연도) |
USD 5.67 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
글로벌 API 중간체 시장, 유형별(수의학 약물 중간체, 제약/대량 약물 중간체), 제품(브로모 화합물, O-벤질 살부타몰, 헤미술페이트, 옥시란, 비소프롤올 염기, 키랄 PCBHP, 페니라민 염기, 클로로페니라민 염기, 브롬페니라민 염기, 메피라민/피릴라민 염기, 6-아미노-1,3-디메틸 우라실, 테오필린, 아세필린, 잔틴, 니트릴, 기타), 치료 유형(자가면역 질환, 종양학, 대사 질환, 안과, 심혈관 질환, 감염성 질환, 신경학, 호흡기 질환, 피부과, 비뇨기과, 기타), 고객(직접 사용자/제약 회사, 상인/도매업체/유통업체, 협회/정부 기관/민간 기관), 최종 사용자(API) 제조업체, 완제품 제조업체), 유통 채널(직접 입찰, 소매 판매, 기타) - 산업 동향 및 2030년까지의 전망.
글로벌 API 중간체 시장 분석 및 규모
활성 약리 성분은 약물 제품의 제조에 사용되도록 의도된 물질 또는 물질의 조합으로, 약물 생산에 사용되면 활성 약리 성분이 됩니다. 이러한 물질은 약리학적 활동을 제공하는 데 사용됩니다.
Data Bridge Market Research는 2022년에 23억 4천만 달러였던 글로벌 API 중간체 시장이 2030년까지 56억 7천만 달러에 도달할 것으로 예상되며, 2023-2030년 예측 기간 동안 7.10%의 CAGR을 기록할 것으로 분석했습니다. "제약/대량 약물 중간체"는 제약 산업의 성장으로 인해 글로벌 API 중간체 시장의 유형 세그먼트를 지배하고 있습니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.
API 중간체 시장 범위 및 세분화
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2021까지 사용자 정의 가능) |
|
양적 단위 |
매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시 |
|
다루는 세그먼트 |
Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa |
|
Market Players Covered |
|
|
Market Opportunities |
|
Market Definition
When discussing medicines and chemical synthesis, the term "API intermediates" refers to the many chemical compounds and materials created throughout the lengthy process of synthesising an Active Pharmaceutical Ingredient (API). The active ingredients (APIs) of a medicine are those that give it its therapeutic action. The creation of APIs frequently entails a number of chemical reactions, purification procedures, and conversions of raw ingredients into the desired finished product. Various intermediate compounds are created throughout this process, each acting as a stepping stone towards the final API. These intermediaries might have unique chemical characteristics, structures, and applications.
Global API Intermediates Market Dynamics
Drivers
- Growing Pharmaceutical Industry
Due to factors like ageing populations, rising healthcare costs, and the demand for novel and creative treatments, the pharmaceutical business is still growing globally. This expansion fuels the need for API intermediates, which are crucial ingredients in the production of pharmaceuticals.
- Rising Technological Advancements
The efficiency and cost-effectiveness of the manufacturing of API intermediates are improved by developments in chemical synthesis and process technologies, thus fuelling market expansion.
- Increasing Demand of Biopharmaceuticals
The need for bioprocess intermediates has expanded as a result of the rise in biopharmaceuticals such recombinant proteins and monoclonal antibodies. These steps in the process are necessary to produce biologics, which is helping to drive market growth.
Opportunities
- Growing Demand of Personalized Medicine
The development of APIs and intermediates customised to particular patient profiles is required by the trend towards personalised medicine and targeted medicines, which can stimulate research and development in this field.
- Rising Collaboration and Partnerships
Innovative solutions and access to new markets can result from collaboration between API intermediate producers, pharmaceutical firms, and research organisations.
- Increasing Focus Towards Green and Sustainable Chemistry
There is a chance for API intermediate producers to create and deliver greener and more sustainable chemical processes and intermediates as sustainability and environmentally friendly practises receive increasing attention.
Restrains/ Challenges
- Strict Regulations
In the pharmaceutical sector, strict regulatory regulations can be a major barrier. It can be expensive and time-consuming to comply with and keep up with rules like Good Manufacturing Practises (GMP) and limit market growth.
- Supply Chain Disruptions
Due to the fact that many manufacturers rely on a complicated global network of suppliers for their raw materials and intermediates, the global API intermediates market is vulnerable to supply chain disruptions. The supply chain may be hampered by unforeseen circumstances like natural disasters or political unrest.
- Safety Concerns
A top priority is to ensure the security of industrial procedures and the safety of employees. Hazardous substances and reactions can be used in the chemical synthesis process.
- High Costs
The cost-effectiveness and supply chain stability of the manufacturing of API intermediates can be affected by changes in the prices and availability of raw materials and chemicals.
이 글로벌 API 중간체 시장 보고서는 최근의 새로운 개발, 무역 규정, 수출입 분석, 생산 분석, 가치 사슬 최적화, 시장 점유율, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출처, 시장 규정의 변화, 전략적 시장 성장 분석, 시장 규모, 범주 시장 성장, 응용 분야 틈새 시장 및 지배력, 제품 승인, 제품 출시, 지리적 확장, 시장의 기술 혁신에 대한 분석 기회를 제공합니다. 글로벌 API 중간체 시장에 대한 자세한 정보를 얻으려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 받으세요. 저희 팀은 시장 성장을 달성하기 위한 정보에 입각한 시장 결정을 내리는 데 도움을 드립니다.
글로벌 API 중간체 시장 범위
글로벌 API 중간체 시장은 유형, 제품, 치료적 클래스, 고객, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
유형
- 수의약 중간체
- 제약/대량 약물 중간체
제품
- 브로모 화합물
- O-벤질 살부타몰
- 헤미황산염
- 옥시란
- 비소프롤올 베이스
- 키랄 PCBHP
- 페니라민베이스
- 클로르페니라민 베이스
- 브롬페니라민 베이스
- 메피라민/피릴라민 베이스
- 6-아미노-1,3-디메틸우라실
- 테오필린
- 아세필린
- 잔틴
- 니트릴
- 기타
치료 유형
- 자가면역질환
- 종양학
- 대사성 질환
- 안과학
- 심혈관 질환
- 감염성 질환
- 신경학
- 호흡기 질환
- 피부과
- 비뇨기과
- 기타
고객
- 직접 사용자/제약 회사
- 상인/도매상/유통업체
- 협회/정부 기관/민간 기관
최종 사용자
- API 제조업체
- 완제품 제조업체
유통채널
- 직접 입찰
- 소매 판매
- 기타
글로벌 API 중간체 시장 지역 분석/통찰력
글로벌 API 중간체 시장을 분석하고, 위에 언급된 국가, 유형, 제품, 치료 유형, 고객, 최종 사용자 및 유통 채널을 기반으로 시장 규모 정보를 제공합니다.
글로벌 API 중간체 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코, 독일, 영국, 프랑스, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 기타 유럽, 일본, 중국, 호주, 인도, 한국, 싱가포르, 인도네시아, 태국, 말레이시아, 필리핀, 베트남, 기타 아시아 태평양, 브라질, 아르헨티나, 페루, 기타 남미, 사우디 아라비아, 남아프리카, UAE, 이스라엘, 쿠웨이트, 이집트, 기타 중동 및 아프리카입니다.
북미는 글로벌 API 중간체 시장을 주도하고 있으며, 2023년부터 2030년까지의 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상됩니다. 이는 의료비 지출이 증가하고 제약/대량 약물 중간체 부문을 위한 잘 확립된 의료 인프라가 있기 때문입니다.
아시아 태평양 지역은 글로벌 API 중간체 시장의 성장을 선도하고 있으며, 제약/대량 약물 중간체 부문은 API 중간체의 저렴한 가격 가용성 증가로 인해 국가에서 우세합니다. 독일의 제약/대량 약물 중간체 부문은 API 중간체에 대한 소비 수요가 증가함에 따라 글로벌 API 중간체 시장에서 우세합니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
의료 인프라 성장 설치 기반 및 신기술 침투
글로벌 API 중간체 시장은 또한 환자 분석, 예후 및 치료법에 대한 자세한 시장 분석을 제공합니다. 유병률, 발생률, 사망률, 준수율은 보고서에서 사용할 수 있는 일부 데이터 변수입니다. 시장 성장에 대한 역학의 직접 또는 간접 영향 분석을 분석하여 2023-2030년 성장 기간 동안 시장을 예측하기 위한 보다 견고하고 코호트 다변량 통계 모델을 만듭니다.
경쟁 환경 및 API 중간체 시장 점유율 분석
글로벌 API 중간체 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 제공된 위의 데이터 포인트는 글로벌 API 중간체 시장과 관련된 회사의 초점에만 관련됩니다.
글로벌 API 중간체 시장에서 활동하는 주요 기업은 다음과 같습니다.
- HIKAL Ltd. (인도)
- 캠브렉스 코퍼레이션(미국)
- Ganesh-Group, AlzChem Group AG(인도)
- Vasudha Pharma(인도)
- 안양종합화학(주) (중국)
- 사렉스(인도)
- Sandoo Pharmaceuticals and Chemicals Co., Ltd (인도)
- Atul Ltd(인도)
- Sandoz International GmbH (Novartis AG의 자회사) (독일)
- 아세토(미국)
- Supriya Lifescience Ltd. (인도)
- LEVACHEM COMPANY LIMITED (중국)
- 베르텔루스(미국)
- Dishman Carbogen Amcis Ltd(인도)
- 사노피(프랑스)
- Divi's Laboratories Limited(인도)
- AARTI INDUSTRIES LIMITED(인도)
- Aurobindo Pharma(인도)
- BASF SE(독일)
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL API intermediates MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET type COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
- Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
- Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
- GLOBAL API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
- THE U.S.-CHINA TRADE WAR
- INDO-CHINA GEOPOLITICAL ISSUES
- CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
- CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
- Cost Analysis
- Analysis on China API intermediates:
- Conclusion:
- porters five forces model
- Pestel analysis
- global API INTERMEDIATES market: regulatORY
- THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
- CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
- EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
- JAPAN REGULATORY FOR API INTERMEDIATES
- MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
- GLOBAL API INTERMEDIATES MARKET: CONCLUSION
- TOP PRODUCTS AND THERAPEUTIC AREAS
- ADDITIONAL
- CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
- LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
- Market Overview
- Drivers
- HIGH BURDEN OF CHRONIC DISEASES
- increase in aging population
- utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
- increasing disease awareness and education
- research and development regarding pharmaceutical API and their intermediates
- restrainTs
- availability of sub-standard and counterfeit drugs
- product recalls
- high manufacturing cost
- stringent government regulations for api intermediates
- opportunities
- strategic initiatives by the market players
- increasing healthcare expenditure
- SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
- RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
- challenges
- disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
- lack of workforce in pharma industries
- Impact of COVID 19 on Global API Intermediates market
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIIN
- STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
- CONCLUSION
- global API intermediates MARKET, BY type
- overview
- pharmaceutical intermediates/ bulk drug intermediates
- Veterinary Drug Intermediates
- global API intermediates MARKET, BY product
- overview
- Nitriles
- bromo compound
- Chiral PCBHP
- Chlorpheniramine Base
- Brompheniramine Base
- Pheniramine Base
- O-Benzyl Salbutamol
- Bisoprolol Base
- Hemisulfate
- Oxirane
- Mepyramine/Pyrilamine Base
- Theofylline
- Acefylline
- Xanthine
- 6-Amino-1,3-Dimethyl Uracil
- others
- global API intermediates MARKET, BY therapeutic type
- overview
- Cardiovascular Diseases
- Metabolic Diseases
- infectious Diseases
- respiratory Diseases
- neurology
- oncology
- Autoimmune Disease
- Dermatology
- ophthalmology
- urology
- others
- global API intermediates MARKET, BY customers
- overview
- Direct Users/Pharma Companies
- Traders/Wholesalers/Distributors
- Associations/Govt. Institutions/Pvt Institutions
- global API intermediates MARKET, BY End User
- overview
- API manufacturer
- finished product manufacturer
- global API intermediates MARKET, BY distribution channel
- overview
- direct tender
- Retail Sale
- others
- Global API Intermediates Market by geography
- Overview
- NORTH AMERICA
- U.S
- CANADA
- MEXICO
- EUROPE
- GERMANY
- U.K
- ITALY
- SPAIN
- FRANCE
- NETHERLANDS
- RUSSIA
- SWITZERLAND
- TURKEY
- AUSTRIA
- NORWAY
- HUNGARY
- LITHUANIA
- IRELAND
- POLAND
- REST OF ASIA PACIFIC
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- SINGAPORE
- MALAYSIA
- THAILAND
- INDONESIA
- PHILIPPINES
- VIETNAM
- REST OF ASIA PACIFIC
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- PERU
- REST OF SOUTH AMERICA
- MIDDLE EAST & AFRICA
- SAUDI ARABIA
- SOUTH AFRICA
- UAE
- ISRAEL
- KUWAIT
- EGYPT
- REST OF MIDDLE EAST & AFRICA
- Global API Intermediates Market: COMPANY landscape
- company share analysis: global
- company share analysis: north america
- company share analysis: europe
- company share analysis: Asia-Pacific
- swot analysis
- company profile
- aurobindo pharma
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- Divi’s laboratories limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- basf se
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- CAMBRIX CORPORATION
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Sandoz International GmbH (a subsidiary of Novartis AG)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- aceto
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- hikal ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- alzchem group ag
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- vertellus
- COMPANY SNAPSHOT
- PRODUCT CATEGORIES
- RECENT DEVELOPMENTS
- sanofi
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- atul ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- aarti industries limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- vasudha pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- anyang general chemical co., Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORFOLIO
- RECENT DEVELOPMENT
- dishman carbogen amics ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- ganesh-group
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- levachem company limited
- COMPANY SNAPSHOT
- PRODUCT PORFOLIO
- RECENT DEVELOPMENT
- sandoo pharmaceuticals and chemicals co., ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- sarex
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SUPRIYA LIFESCIENCE LTD.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
표 목록
TABLE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)
TABLE 2 Percentage Break up of Cost
TABLE 3 Tentative Land Requirement
TABLE 4 Percentage Break up of Plant Area
TABLE 5 Table: 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE
TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 7 MARKET PLAYERS OF API INTERMEDIATES
TABLE 8 Sales Data of API intermediates for 2019/2020
TABLE 9 Global API intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 10 Global pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 11 Global Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 12 Global API intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 13 Global nitriles in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 14 Global bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 15 Global chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 16 Global chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 17 Global brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 18 Global pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 19 Global O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 20 Global bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 21 Global hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 22 Global oxirane in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 23 Global mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 24 Global theofylline in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 25 Global acefylline in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 26 Global Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 27 Global 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 28 Global others in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 29 Global API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)
TABLE 30 globaL cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)
TABLE 31 globaL metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 32 globaLinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 33 globaL respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 34 globaL neurology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 35 globaL oncology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 36 globaL autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 37 globaL dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 38 globaL ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 39 globaL urology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 40 globaL others in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 41 Global API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)
TABLE 42 globaL Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 43 globaL Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 44 globaL Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 45 Global API intermediates Market, By END USER, 2019-2028 (USD Million)
TABLE 46 Global API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 47 Global finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 48 Global API intermediates Market, By distribution channel, 2019-2028 (USD Million)
TABLE 49 globaL direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 50 globaL retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 51 globaL Othersin API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 52 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS MARKET, BY REGION , 2021-2028 (USD MILLION)
TABLE 53 NORTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 54 North America API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 55 North America API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 56 North America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 57 North America API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 58 North America API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 59 North America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 60 U.S API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 61 U.S API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 62 U.S API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 63 U.S API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 64 U.S API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 65 U.S API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 66 Canada API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 67 Canada API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 68 Canada API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 69 Canada API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 70 Canada API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 71 Canada API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 72 MEXICO API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 73 MEXICO API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 74 MEXICO API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 75 MEXICO API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 76 MEXICO API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 77 MEXICO API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 78 Europe API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 79 Europe API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 80 Europe API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 81 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 82 Europe API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 83 Europe API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 84 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 85 Germany API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 86 Germany API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 87 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 88 Germany API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 89 Germany API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 90 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 91 U.K API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 92 U.K API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 93 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 94 U.K API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 95 U.K API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 96 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 97 U.K API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 98 Italy API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 99 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 100 Italy API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 101 Italy API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 102 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 103 Spain API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 104 Spain API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 105 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 106 Spain API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 107 Spain API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 108 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 109 France API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 110 France API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 111 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 112 France API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 113 France API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 114 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 115 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 116 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 117 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 118 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 119 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 120 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 121 Russia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 122 Russia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 123 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 124 Russia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 125 Russia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 126 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 127 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 128 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 129 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 130 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 131 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 132 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 133 Turkey API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 134 Turkey API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 135 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 136 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 137 Turkey API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 138 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 139 Austria API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 140 Austria API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 141 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 142 Austria API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 143 Austria API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 144 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 145 Norway API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 146 Norway API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 147 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 148 Norway API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 149 Norway API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 150 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 151 Hungary API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 152 Hungary API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 153 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 154 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 155 Hungary API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 156 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 157 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 158 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 159 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 160 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 161 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 162 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 163 Ireland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 164 Ireland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 165 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 166 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 167 Ireland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 168 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 169 Poland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 170 Poland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 171 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 172 Poland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 173 Poland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 174 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 175 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 176 ASIA-PACIFIC API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 177 Asia-Pacific API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 178 Asia-Pacific API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 179 Asia-Pacific API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 180 Asia-Pacific API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 181 Asia-Pacific API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 182 Asia-Pacific API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 183 China API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 184 China API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 185 China API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 186 China API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 187 China API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 188 China API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 189 India API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 190 India API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 191 India API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 192 India API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 193 India API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 194 India API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 195 India API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 196 Japan API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 197 Japan API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 198 Japan API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 199 Japan API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 200 Japan API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 201 australia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 202 Australia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 203 Australia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 204 Australia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 205 Australia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 206 Australia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 207 South Korea API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 208 South Korea API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 209 South Korea API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 210 South Korea API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 211 South Korea API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 212 South Korea API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 213 Singapore API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 214 Singapore API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 215 Singapore API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 216 Singapore API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 217 Singapore API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 218 Singapore API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 219 Malaysia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 220 Malaysia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 221 Malaysia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 222 Malaysia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 223 Malaysia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 224 Malaysia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 225 Thailand API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 226 Thailand API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 227 Thailand API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 228 Thailand API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 229 Thailand API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 230 Thailand API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 231 Indonesia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 232 Indonesia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 233 Indonesia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 234 Indonesia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 235 Indonesia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 236 Indonesia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 237 Philippines API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 238 Philippines API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 239 Philippines API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 240 Philippines API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 241 Philippines API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 242 Philippines API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 243 Vietnam API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 244 Vietnam API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 245 Vietnam API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 246 Vietnam API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 247 Vietnam API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 248 Vietnam API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 249 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 250 SOUTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 251 South America API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 252 South America API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 253 South America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 254 South America API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 255 South America API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 256 South America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 257 BRAZIL API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 258 BRAZIL API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 259 BRAZIL API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 260 BRAZIL API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 261 BRAZIL API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 262 BRAZIL API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 263 Argentina API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 264 Argentina API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 265 Argentina API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 266 Argentina API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 267 Argentina API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 268 Argentina API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 269 PERU API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 270 PERU API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 271 PERU API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 272 PERU API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 273 PERU API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 274 PERU API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 275 Rest of South America API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 276 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 277 Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 278 Middle East & Africa API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 279 Middle East & Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 280 Middle East & Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 281 Middle East & Africa API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 282 Middle East & Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 283 Saudi Arabia API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 284 Saudi Arabia API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 285 Saudi Arabia API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 286 Saudi Arabia API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 287 Saudi Arabia API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 288 Saudi Arabia API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 289 South Africa API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 290 South Africa API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 291 South Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 292 South Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 293 South Africa API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 294 South Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 295 UAE API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 296 UAE API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 297 UAE API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 298 UAE API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 299 UAE API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 300 UAE API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 301 Israel API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 302 Israel API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 303 Israel API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 304 Israel API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 305 Israel API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 306 Israel API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 307 Kuwait API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 308 Kuwait API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 309 Kuwait API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 310 Kuwait API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 311 Kuwait API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 312 Kuwait API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 313 Egypt API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 314 Egypt API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 315 Egypt API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 316 Egypt API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 317 Egypt API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 318 Egypt API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 319 Rest of Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)
그림 목록
FIGURE 1 Global API INTERMEDIATES MARKET: SEGMENTATION
FIGURE 2 GLOBAL API INTERMEDIATES MARKET: DATA TRIANGULATION
FIGURE 3 global API intermediates Market: DROC ANALYSIS
FIGURE 4 Global API intermediates market: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 Global API intermediates Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL API intermediates MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL API intermediates MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL API intermediates MARKET: MARKET type COVERAGE GRID
FIGURE 11 Global API intermediates market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL API intermediates market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 north america is the fastest growing market FOR the API intermediates MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE global API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 15 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the global API INTERMEDIATES MARKET in 2021 & 2028
FIGURE 16 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Global API Intermediates market
FIGURE 17 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019
FIGURE 18 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020
FIGURE 19 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020
FIGURE 20 10 GLOBAL CAUSES OF DEATHs WITH THE CHRONIC DISEASES
FIGURE 21 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)
FIGURE 22 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
FIGURE 23 global API intermediates market: BY type, 2021
FIGURE 24 global API intermediates market: BY type, 2019-2028 (USD Million)
FIGURE 25 global API intermediates market: BY type, CAGR (2021-2028)
FIGURE 26 global API intermediates market: BY type, LIFELINE CURVE
FIGURE 27 global API intermediates market: BY product, 2021
FIGURE 28 global API intermediates market: BY product, 2019-2028 (USD Million)
FIGURE 29 global API intermediates market: BY product, CAGR(2021-2028)
FIGURE 30 global API intermediates market: BY product, LIFELINE CURVE
FIGURE 31 global API intermediates market: BY therapeutic type, 2021
FIGURE 32 global API intermediates market: BY therapeutic type, 2019-2028 (USD Million)
FIGURE 33 global API intermediates market: BY therapeutic type, CAGR (2021-2028)
FIGURE 34 global API intermediates market: BY therapeutic type, LIFELINE CURVE
FIGURE 35 global API intermediates market: BY customers, 2021
FIGURE 36 global API intermediates market: BY customers, 2019-2028 (USD Million)
FIGURE 37 global API intermediates market: BY customers, CAGR (2021-2028)
FIGURE 38 global API intermediates market: BY customers, LIFELINE CURVE
FIGURE 39 global API intermediates market: BY end user, 2021
FIGURE 40 global API intermediates market: BY end user, 2019-2028 (USD Million)
FIGURE 41 global API intermediates market: BY end user, CAGR (2021-2028)
FIGURE 42 global API intermediates market: BY end user, LIFELINE CURVE
FIGURE 43 global API intermediates market: BY distribution channel, 2021
FIGURE 44 global API intermediates market: BY distribution channel, 2019-2028 (USD Million)
FIGURE 45 global API intermediates market: BY distribution channel, CAGR (2021-2028)
FIGURE 46 global API intermediates market: BY distribution channel, LIFELINE CURVE
FIGURE 47 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: SNAPSHOT (2020)
FIGURE 48 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020)
FIGURE 49 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2021 & 2028)
FIGURE 50 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020 & 2028)
FIGURE 51 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY type (2021-2028)
FIGURE 52 North America API Intermediates market: SNAPSHOT (2020)
FIGURE 53 North America API Intermediates market: BY COUNTRY (2020)
FIGURE 54 North America API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 55 North America API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 56 North America API Intermediates market: BY type (2021-2028)
FIGURE 57 Europe API Intermediates market: SNAPSHOT (2020)
FIGURE 58 Europe API INTERMEDIATEs market: BY COUNTRY (2020)
FIGURE 59 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)
FIGURE 60 Europe API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 61 Europe API Intermediates market: BY type (2021-2028)
FIGURE 62 Asia-Pacific API Intermediates market: SNAPSHOT (2020)
FIGURE 63 Asia-Pacific API Intermediates market: BY COUNTRY (2020)
FIGURE 64 Asia-Pacific API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 65 Asia-Pacific API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 66 Asia-Pacific API Intermediates market: BY type (2021-2028)
FIGURE 67 South America API Intermediates market: SNAPSHOT (2020)
FIGURE 68 South America API Intermediates market: BY COUNTRY (2020)
FIGURE 69 South America API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 70 South America API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 71 South America API Intermediates market: BY type (2021-2028)
FIGURE 72 Middle East & Africa API Intermediates market: SNAPSHOT (2020)
FIGURE 73 Middle East & Africa API Intermediates market: BY COUNTRY (2020)
FIGURE 74 Middle East & Africa API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 75 Middle East & Africa API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 76 Middle East & Africa API Intermediates market: BY type (2021-2028)
FIGURE 77 Global API Intermediates market: company share 2020 (%)
FIGURE 78 North America API Intermediates Market: company share 2020 (%)
FIGURE 79 EUROPE API Intermediates Market: company share 2020 (%)
FIGURE 80 ASIA-PACIFIC API Intermediates Market: company share 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
